Core Viewpoint - The article emphasizes the importance of facilitating the transformation of clinical innovations into medical products that benefit patients, highlighting Beijing's "Spring Rain Action" as a key initiative to enhance innovation in the medical and health industry [1] Group 1: Policy and Support Mechanisms - Beijing has established a "policy coordination + full-chain service" support system to optimize the innovation environment, combining top-level design with systematic policy support [2] - Since 2018, Beijing has implemented three rounds of collaborative innovation action plans in the medical and health sector, introducing measures to support high-quality development in innovative pharmaceuticals [2] - The "Spring Rain Action," led by the National Medical Products Administration, was launched in April 2025, creating a collaborative mechanism among various departments to promote the transformation of innovative medical device results [2][3] Group 2: Innovation Ecosystem Development - Beijing has built an innovation ecosystem characterized by city-district collaboration and medical-enterprise cooperation, enhancing the internal motivation for deep collaboration between medical institutions and enterprises [4] - As of October 2025, the Beijing Medical Products Administration has collected information on 220 medical device projects, with 87 projects selected for focused cultivation, marking a new phase in the "Spring Rain Action" [4] - The collaboration mechanism ensures that innovative products are closely aligned with clinical needs from the design stage, facilitating safe and effective applications in clinical settings [6] Group 3: Product Development and Market Entry - The Beijing Medical Products Administration has implemented a "graded cultivation + review linkage" mechanism to support product market entry, providing tailored guidance for different categories of medical devices [7] - As of December 2025, one third-class medical device has entered the special review process, with four third-class devices prioritized for approval, demonstrating the effectiveness of the "Spring Rain Action" [7] - The initiative aims to create a comprehensive innovation ecosystem that integrates policy innovation, clinical resources, and industry collaboration, ensuring sustainable growth in the medical health sector [8]

Core Viewpoint - The implementation plan for the comprehensive reform of drug, medical device, and cosmetic regulation in Hainan Province aims to promote high-quality development of the pharmaceutical industry through various supportive measures for innovative drugs and medical devices [1] Group 1: Support for Innovative Drugs and Devices - The plan includes timely updates to the "Hainan Province Innovative Drug and Device Product Directory," allowing new drugs, first-generic drugs, and generics that pass quality and efficacy consistency evaluations, as well as certain classes of medical devices, to be included for procurement by medical institutions [1] - There is an emphasis on accelerating the use of innovative drugs and devices in hospitals by establishing a long-term mechanism for regular meetings of pharmacy, device management, and pharmacotherapy committees in public hospitals [1] - The initiative aims to facilitate the inclusion of innovative drugs and devices in the national medical insurance negotiations, providing guidance to companies to help eligible products enter the insurance directory [1] Group 2: Pricing and Market Access - A mechanism for the formation of initial pricing and full-cycle price management for innovative medical devices will be established, promoting rapid online trading through price negotiation between supply and demand parties for devices without listed prices [1]